Abstract: A cooling member located in an upper part of a battery cell stack in which a plurality of battery cells are stacked includes an upper plate, a lower plate, and a coolant incorporated in an inner space between the upper plate and the lower plate. The lower plate includes a first part in which a fragile part is formed, and a second part in which the fragile part is not formed. A thickness value of the first part is smaller than a thickness value of the second part.

Abstract: Disclosed are semiconductor devices, electronic systems including the same, and methods of fabricating the same. The semiconductor device comprises a first gate stack structure including a first dielectric pattern and a first conductive pattern that are alternately stacked with each other, a memory channel structure including a first memory portion that penetrates the first gate stack structure, a through contact including a first through portion at a level the same as a level of the first memory portion, and a connection contact including a first connection portion at a level the same as the level of the first memory portion and the level of the first through portion. A minimum width of the first memory portion is less than a minimum width of the first through portion and a minimum width of the first connection portion.

Abstract: The present disclosure relates to an isolated anti-FcRN antibody, which is an antibody binding to FcRN (stands for neonatal Fc receptor, also called FcRP, FcRB or Brambell receptor) that is a receptor with a high affinity for IgG or a fragment thereof, a method of preparing thereof, a composition for treating autoimmune disease, which comprises the antibody, and a method of treating and diagnosing autoimmunre diseases using the antibody. The FcRn-specific antibody according to the present disclosure binds to FcRn non-competitively with IgG to reduce serum pathogenic auto-antibody levels, and thus can be used for the treatment of autoimmune diseases.

Abstract: Disclosed are a method for extracting a compound represented by Chemical Formula 1 from ginseng, including anaerobic natural fermentation of ginseng, an anaerobic-naturally fermented ginseng extract including the compound represented by Chemical Formula 1 extracted by the method, and a method of enhancing the skin barrier including applying a composition including an effective amount of the anaerobic-naturally fermented ginseng extract. In Chemical Formula 1, each substituent is as defined in the specification.

Abstract: The present invention relates to a dual-body drug administration device which administers drugs and removes mucus from the paranasal sinus through the nostrils in order to prevent or treat a paranasal sinus disease and, more specifically, to a device in which two injectors having adapters coupled thereto are integrally fixed by a fixing holder, the adapters of the fixed injectors are simultaneously brought into contact with both the nostrils, and then negative pressure is generated in the nasal cavity to pull out mucus from the paranasal sinus or administer a drug to the paranasal sinus.

Abstract: Disclosed is a method, system, and non-transitory computer-readable record medium for immediate or prompt cryptocurrency trading. A cryptocurrency trading method includes receiving, by at least one processor, a transfer request from a user for a transfer transaction to a second party exchange from a first party exchange, the first party exchange being provided by the computer system, and processing, by the at least one processor, the transfer transaction as an internal transaction in response to the transfer request by using a first party account without using a blockchain network, the first party account being an account of the first party exchange on the second party exchange.

Abstract: The present invention relates to a liquid drug injection device for injecting a liquid drug into a nasal cavity and paranasal sinuses through a nostril and, more specifically, to a device for injecting a liquid drug into a nasal cavity and paranasal sinuses, so as to enhance the effect of cleaning surfaces of the nasal cavity and the paranasal sinuses and injecting the liquid drug, and to increase the effectiveness of preventing and treating nasal diseases.

Abstract: The present invention relates to a solid composition comprising an iodine agent and sodium chloride having improved water solubility and to an antiviral and antimicrobial composition for an eye, oral cavity, nasal cavity or inhalation containing an aqueous solution thereof, wherein the solid composition comprises an iodine agent and sodium chloride or a mixture of an iodine agent, sodium chloride and a flavoring agent and is excellent in not only storage stability but also water solubility as a dissolution rate thereof for water is 30 seconds or less.